Citations

Citations to this article as recorded by  

• Survival after Subthalamic Deep Brain Stimulation for Parkinson's Disease: 25‐Year Experience from a Single Center
  Sayooja Sachithanandan, Athul Sreelatha Sanjeev, Jissa Vinoda Thulaseedharan, Krishnakumar Kesavapisharady, Divya Kalikavil Puthanveedu, Asish Vijayaraghavan, Gangadhara Sarma, Syam Krishnan, Asha Kishore
  Movement Disorders Clinical Practice.2026; 13(3): 723.     CrossRef
• Physical Exercise and Survival in Parkinson’s Disease: A Cohort Study
  Priscila Rodrigues Gil, Juliana da Silveira, Adriano Ferreti Borgatto, Jéssica Amaro Moratelli, Anelise Sonza, Adriana Coutinho de Azevedo Guimarães
  Research Quarterly for Exercise and Sport.2026; 97(2): 341.     CrossRef
• Biological aging predicts mortality in Parkinson’s patients: evidence from UK Biobank
  Qing-Qing Duan, Wei-Ming Su, Kang-Fu Yin, Sheng-Yi He, Ru-Yin Liu, Xiang-Jin Wen, Xiao-Jing Gu, Ting Chen, Bei Cao, Yong-Ping Chen
  npj Parkinson's Disease.2026;[Epub]     CrossRef
• Long-Term Mortality and 10-Year Outcomes after Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease
  Hikaru Kamo, Genko Oyama, Mai Shimizu, Masanobu Ito, Hirokazu Iwamuro, Atsushi Umemura, Taku Hatano, Nobutaka Hattori
  Stereotactic and Functional Neurosurgery.2026; : 1.     CrossRef
• Dementia Incidence in Individuals With Parkinson's Disease in the Framingham Heart Study
  Joshi Dookhy, Michael Cummings, Eden Price, Yulin Liu, Santiago Gutierrez‐Gomez, Sarah O'Shea, Samuel Frank, Rhoda Au, Ashita S. Gurnani, Ting Fang Alvin Ang, Jesse Mez, Ludy C. Shih
  Annals of Clinical and Translational Neurology.2026;[Epub]     CrossRef
• Case Definitions and Data Sources for NNCSS Parkinson Disease Surveillance
  Christine D. Esper, Kelly N. Hogan, Purni Abeysekara, Kasey Nichole Smith, Tenbroeck G. Smith, Shawna L. Mercer
  JAMA Network Open.2026; 9(6): e2613928.     CrossRef
• Bile Acid Dysregulation in Parkinson’s Disease: Longitudinal Changes and Altered Metabolic Interactions
  Andrea Ižarik Verešpejová, Marián Grendár, Martin Kertys, Natália Huňarová, Li Sheng Chien, Milan Grofik, Michaela Škorvanová, Jakub Šofranko, Nela Žideková, Egon Kurča, Martin Kolísek
  Biomolecules.2026; 16(6): 875.     CrossRef
• Exploring Non-invasive Brain Stimulation Effects on Physical Outcomes in People With Parkinson’s Disease: An Umbrella Evidence Mapping Review With Meta-analyses
  Dale M. Harris, Christopher Latella, Nicholas Tripodi, Steven J. O’Bryan
  Neurorehabilitation and Neural Repair.2025; 39(4): 321.     CrossRef
• La maladie de Parkinson : de la génétique aux thérapies ciblées
  Guillaume Cogan, Alexis Brice
  Comptes Rendus. Biologies.2025; 348(G1): 21.     CrossRef
• A nationwide retrospective cohort study of the association between acupuncture exposure and clinical outcomes of idiopathic Parkinson’s disease using health insurance claim data in South Korea
  Ye-Chae Hwang, Jungkuk Lee, Dongwoo Kang, Han-Gyul Lee, Seungwon Kwon, Seung-Yeon Cho, Seong-Uk Park, Woo-Sang Jung, Sang-Kwan Moon, Jung-Mi Park, Jungtae Leem, Chang-Nam Ko
  Integrative Medicine Research.2025; 14(2): 101146.     CrossRef
• Mortality and causes of death in patients with Parkinson's disease in Taiwan
  Shang-Jyh Chiou, Ya-Hui Hu, Yun-Chung Chen, Da-ling Wang, Alexis Elbaz, Pei-Chen Lee
  Journal of Parkinson’s Disease.2025; 15(4): 819.     CrossRef
• All-Cause and Cause-Specific Mortality in Parkinson’s Disease: A Meta-Analysis
  Young Ho Lee, Gwan Gyu Song
  Neuroepidemiology.2025; 60(2): 398.     CrossRef
• Update: Descriptive epidemiology of Parkinson disease
  Nikolas Grotewold, Roger L. Albin
  Parkinsonism & Related Disorders.2024; 120: 106000.     CrossRef
• Cost-effectiveness Analysis of COMT-inhibitors as Adjuvant Treatments to Levodopa in Patients with Advanced Parkinson's Disease
  Nayoung Kwak, Myung-Jun Lee, Hye-Young Kang, Hankil Lee
  Clinical Therapeutics.2024; 46(9): 670.     CrossRef
• Profiling people with Parkinson's disease at risk of cognitive decline: Insights from PPMI and ICICLE‐PD data
  Dana Pourzinal, Rachael A. Lawson, Alison J. Yarnall, Caroline H. Williams‐Gray, Roger A. Barker, Jihyun Yang, Katie L. McMahon, John D. O'Sullivan, Gerard J. Byrne, Nadeeka N. Dissanayaka
  Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.2024;[Epub]     CrossRef
• Risk of aspiration pneumonia and hospital mortality in Parkinson disease: A systematic review and meta‐analysis
  Wei Yu Chua, Jia Dong James Wang, Claire Kar Min Chan, Ling‐Ling Chan, Eng‐King Tan
  European Journal of Neurology.2024;[Epub]     CrossRef
• Psychometric properties of Arabic-translated-related quality of life scales for people with parkinson disease: a scoping review
  Chiraz Azaiez, Naser Chalghaf, Amayra Tannoubi, Noomen Guelmami, Medina Srem-Sai, Frank Quansah, John Elvis Hagan, Heifa Sneni, Ghada Boussayala, Imane Ghalmi, Mazin Inhaier Lami, Nicola Luigi Bragazzi, Stephane Mandigout, Choukri ben Ayed, Fairouz Azaiez
  BMC Public Health.2024;[Epub]     CrossRef
• Indication for molecular testing by multiplex ligation‐dependent probe amplification in parkinsonism
  E. Mutez, M. Swiderski, D. Devos, C. Moreau, G. Baille, A. Degardin, G. Ryckewaert, N. Carriere, A. Kreisler, C. Simonin, N. Rouaix, M. Tir, P. Krystkowiak, N. Ramdane, M. Génin, B. Sablonnière, L. Defebvre, V. Huin
  European Journal of Neurology.2023; 30(6): 1667.     CrossRef
• Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease
  Amica C. Müller-Nedebock, Marieke C. J. Dekker, Matthew J. Farrer, Nobutaka Hattori, Shen-Yang Lim, George D. Mellick, Irena Rektorová, Mohamed Salama, Artur F. S. Schuh, A. Jon Stoessl, Carolyn M. Sue, Ai Huey Tan, Rene L. Vidal, Christine Klein, Soraya
  npj Parkinson's Disease.2023;[Epub]     CrossRef
• Effects of omega-3 polyunsaturated fatty acids on the levels of pro- and anti-inflammatory cytokines and lipid profile in patients with Parkinson's disease
  Sara Mohammadi, Mirmohsen Sharifi Bonab, Mahdyieh Hamed Behzad, Bahram Pourghassem Gargari
  Nutrition Clinique et Métabolisme.2023; 37(3): 181.     CrossRef
• The elephant in the room: critical reflections on mortality rates among individuals with Parkinson’s disease
  Lisanne J. Dommershuijsen, Sirwan K. L. Darweesh, Yoav Ben-Shlomo, Benzi M. Kluger, Bastiaan R. Bloem
  npj Parkinson's Disease.2023;[Epub]     CrossRef
• Mortality of Parkinson’s disease in Italy from 1980 to 2015
  Monica Ulivelli, Daiana Bezzini, Lucia Kundisova, Ilaria Grazi, Mario Alberto Battaglia, Nicola Nante, Simone Rossi
  Neurological Sciences.2022; 43(6): 3603.     CrossRef
• A nationwide study of the incidence, prevalence and mortality of Parkinson’s disease in the Norwegian population
  Brage Brakedal, Lilah Toker, Kristoffer Haugarvoll, Charalampos Tzoulis
  npj Parkinson's Disease.2022;[Epub]     CrossRef
• Australian Parkinson’s Genetics Study (APGS): pilot (n=1532)
  Svetlana Bivol, George D Mellick, Jacob Gratten, Richard Parker, Aoibhe Mulcahy, Philip E Mosley, Peter C Poortvliet, Adrian I Campos, Brittany L Mitchell, Luis M Garcia-Marin, Simone Cross, Mary Ferguson, Penelope A Lind, Danuta Z Loesch, Peter M Vissche
  BMJ Open.2022; 12(2): e052032.     CrossRef
• Therapeutic targeting of mitophagy in Parkinson's disease
  Shashank Masaldan, Sylvie Callegari, Grant Dewson
  Biochemical Society Transactions.2022; 50(2): 783.     CrossRef
• Worldwide trends in mortality related to Parkinson's disease in the period of 1994–2019: Analysis of vital registration data from the WHO Mortality Database
  Ioannis C. Lampropoulos, Foteini Malli, Olga Sinani, Konstantinos I. Gourgoulianis, Georgia Xiromerisiou
  Frontiers in Neurology.2022;[Epub]     CrossRef
• Effects of physician visit frequency for Parkinson’s disease treatment on mortality, hospitalization, and costs: a retrospective cohort study
  Takako Fujita, Akira Babazono, Sung-a Kim, Aziz Jamal, Yunfei Li
  BMC Geriatrics.2021;[Epub]     CrossRef